Author Archives: Scalper1

LinkedIn Eases Concerns With Strong Q3 Earnings

As it digests a major acquisition and undergoes a workforce rebalancing, LinkedIn reported better-than-expected third-quarter earnings after the market close Thursday. The networking site for professionals also raised fourth-quarter guidance, sending its stock higher in after-hours trading. LinkedIn (LNKD) reported revenue of $780 million, topping the consensus estimate of $755.8 million and up 37% from the year-earlier quarter.

Valeant Hit As CVS, Express Scripts Dump Philidor

CVS Health (CVS) and Express Scripts (ESRX), the nation’s two largest pharmacy benefit managers, axed the Valeant Pharmaceuticals (VRX)-linked Philidor Rx Services from their networks. Valeant shares plunged 12.2% to 97.94 in after-hours trading on the stock market today. The drugmaker has been hit by questions about its drug-pricing methods as well as its accounting and business practices. Its stock has plunged 63% since hitting an all-time